Report Categories
View AllRecent Articles
View All
Infinite IEAGU Stock Stock Dividend Trend Strengthens 20260418
Is Rich Sparkle ANPA Stock a ShortTerm Play 151 20260415
Abivax ABVX Stock Worth Buying 081 20260416
Morgan Stanley MS
CVS Health Corporation CVS
ASLE AerSale shares notch modest gains despite Q4 2025 earnings falling short of consensus analyst estimates
ACRV Acrivon posts wider than expected Q4 2025 per share loss as its stock edges slightly higher today
Anthropic Calls for Stricter Chip Export Controls as Nvidia CEO Joins Trump in China
Wall Street Makes Massive Bet on BloodBased Cancer Testing Innovation
Straus Family Creamery Recalls Organic Ice Cream Across 17 States Over Metal Fragment Contamination
Profectus BioPharmaceuticals Files Form 10Q Quarterly Report with SEC
RBI Tightens Bank Disclosure Norms More Granular Risk and Capital Reporting Required
Jim Cramer Questions NVIDIAs Valuation Despite Market Strength
TikToks Creator Economy A Surge in Discovery and Revenue for Businesses
Microsoft A Potential LongTerm Holding Amid Cloud and AI Growth
Micron Technology Achieves 1 Trillion Market Cap Milestone Amid AIDriven Memory Demand
Critical Medicines Act Poised to Reshape Pharmaceutical Manufacturing and Supply Resilience in Europe
Trainline Raises Guidance Again Signaling Strong Travel Demand
US Stock Futures and Bond Yields Decline as Putin Updates Nuclear Doctrine
GTEC Q4 2025 Earnings Deep EPS Miss but Stock Surges Over 20
NiSource NI Q1 2026 Earnings Earnings Miss the Mark but Stock Edges Higher
SILC Q1 2026 Earnings Narrower Loss Than Expected Drives Stock Higher
SRPT Q1 2026 Earnings EPS Surges 18467 Above Estimates Amid Strong Gene Therapy Progress
DBX Q1 2026 Earnings EPS Beats Estimates by 8 Amid Modest Stock Uptick
HealthEquity Q1 2026 Earnings EPS Beats Estimates Stock Rises 194
Kimco Realty KIM Edges Higher as Investors Eye Key Resistance at 2532
Calamos Convertible and High Income Fund CHY Edges Higher Amid Steady Support Levels
Digi International Inc DGII Surges Over 3 as Positive Momentum Builds
Allogene Therapeutics ALLO Surges 755 as Biotech Momentum Builds
Aimei Health Technology Rights AFJKR Edges Higher Testing Key Resistance at 030